Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Bioorg Med Chem Lett ; 15(22): 4985-8, 2005 Nov 15.
Article in English | MEDLINE | ID: mdl-16165356

ABSTRACT

Excitatory amino acid transporters (EAATs) play a pivotal role in maintaining glutamate homeostasis in the mammalian central nervous system, with the EAAT-2 subtype thought to be responsible for the bulk of the glutamate uptake in forebrain regions. A complete elucidation of the functional role of EAAT-2 has been hampered by the lack of potent and selective pharmacological tools. In this study, we describe the synthesis and biological activities of novel aryl-ether, biaryl-, and fluorene-aspartic acid and diaminopropionic acid analogs as potent inhibitors of EAAT-2. Compound (16) represents one of the most potent (IC50=85+/-5 nM) and selective inhibitors of EAAT-2 identified to date.


Subject(s)
Aspartic Acid/chemistry , Ether/chemistry , Excitatory Amino Acid Transporter 2/antagonists & inhibitors , Fluorenes/chemistry , Propionates/chemistry , beta-Alanine/analogs & derivatives , beta-Alanine/chemistry , Biological Transport/drug effects , Excitatory Amino Acid Transporter 2/metabolism , Inhibitory Concentration 50 , Molecular Structure , Propionates/chemical synthesis , Structure-Activity Relationship , beta-Alanine/chemical synthesis
2.
Assay Drug Dev Technol ; 2(5): 525-34, 2004 Oct.
Article in English | MEDLINE | ID: mdl-15671650

ABSTRACT

M-channels (M-current), encoded by KCNQ2/3 K(+) channel genes, have emerged as novel drug targets for a number of neurological disorders. The lack of direct high throughput assays combined with the low throughput of conventional electrophysiology (EP) has impeded rapid screening and evaluation of K(+)-channel modulators. Development of a sensitive and efficient assay for the direct measurement of M-current activity is critical for identifying novel M-channel modulators and subsequent investigation of their therapeutic potential. Using a stable CHO cell line expressing rat KCNQ2/3 K(+) channels confirmed by EP, we have developed and validated a nonradioactive rubidium (Rb(+)) efflux assay in a 96-well plate format. The Rb(+) efflux assay directly measures the activity of functional channels by atomic absorption spectroscopy using the automated Ion Channel Reader (ICR) 8000. The stimulated Rb(+) efflux from KCNQ2/3-expressing cells was blocked by the channel blockers XE991 and linopirdine with IC(50) values of 0.15 microM and 1.3 microM, respectively. Twelve compounds identified as KCNQ2/3 openers were further assessed in this assay, and their EC(50) values were compared with those obtained with EP. A higher positive correlation coefficient between these two assays (r = 0.60) was observed than that between FlexStation membrane potential and EP assays (r = 0.23). To simplify the assay and increase the throughput, we demonstrate that EC(50) values obtained by measuring Rb(+) levels in the supernatant are as robust and consistent as those obtained from the ratio of Rb(+) in supernatant/lysate. By measuring the supernatant only, the throughput of ICR8000 in an eight-point titration is estimated to be 40 compounds per day, which is suitable for a secondary confirmation assay.


Subject(s)
Potassium Channels, Voltage-Gated/metabolism , Rubidium/metabolism , Spectrophotometry, Atomic/methods , Animals , CHO Cells , Cricetinae , Dose-Response Relationship, Drug , Ion Channels/antagonists & inhibitors , Ion Channels/metabolism , KCNQ Potassium Channels , KCNQ1 Potassium Channel , Large-Conductance Calcium-Activated Potassium Channels , Potassium Channel Blockers/pharmacology , Potassium Channels, Calcium-Activated , Potassium Channels, Voltage-Gated/antagonists & inhibitors , Rats
SELECTION OF CITATIONS
SEARCH DETAIL
...